Resources

RNA & Oligonucleotides Manufacturing Capabilities Sheet

It is expected that there will be significant growth in the oligonucleotide synthesis market over the next five years owing to factors such as the increasing prevalence of chronic and rare diseases, along with the growing adoption of oligonucleotides in drug development.

The key to RNA & Oligonucleotides manufacturing is flexibility, flexibility in terms of adherence to the requirements for regulatory approval and commercial scale-out by adapting their solutions to incorporate emerging technologies to facilitate the evolving complexity of new compounds.

Download our RNA & Oligonucleotides manufacturing capabilities sheet to find out more about how Symbiosis are well placed to support your RNA & Oligonucleotides manufacturing requirements.